Synthesis of N-(2-pyridyl)imidazolidin-2-ones and 1-(2-pyridyl)-2,3,7,8-tetrahydro-1H-imidazo[2,1-b][1,3,5]triazepin-5(6H)-ones with potential biological activities

被引:6
作者
Balewski, Lukasz [1 ]
Saczewski, Franciszek [1 ]
Gdaniec, Maria [2 ]
Bednarski, Patrick J. [3 ]
Jara, Izabela [1 ]
机构
[1] Med Univ Gdansk, Fac Pharm, Dept Chem Technol Drugs, PL-80416 Gdansk, Poland
[2] Adam Mickiewicz Univ, Fac Chem, PL-60780 Poznan, Poland
[3] Ernst Moritz Arndt Univ Greifswald, Inst Pharm, Dept Pharmaceut & Med Chem, D-17489 Greifswald, Germany
关键词
cytotoxic activity; 1-(2-pyridyl)imidazolidin-2-ones; 1-(2-pyridyl)-2,3,7,8-tetrahydro-1H-imidazo[2,1-b][1,3,5]triazepin-5(6H)-ones; synthesis; theoretical study; X-ray crystallography; COPPER-CATALYZED ARYLATION; PYRIDINE; 1-OXIDES; LEAD DISCOVERY; BINDING-SITE; RAF KINASE; N-OXIDES; INHIBITORS; DERIVATIVES; 2-CHLORO-4,5-DIHYDROIMIDAZOLE; AMINATION;
D O I
10.1515/hc-2013-0125
中图分类号
O62 [有机化学];
学科分类号
070303 ; 081704 ;
摘要
Small libraries of 1-(2-pyridyl)imidazolidin-2-one and 1-(2-pyridyl)-2,3,7,8-tetrahydro-1H-imidazo[2,1-b][1,3,5]triazepin-5(6H)-one derivatives were prepared from substituted pyridine or quinoline N-oxides and 2-chloro-4,5-dihydroimidazole by means of the alpha-ureation and alpha-amination reactions. The alpha-ureation reaction of pyridine and quinoline N-oxides was studied theoretically by means of quantum chemical calculations at the density functional theory level. The newly obtained compounds were screened for their potential in vitro cytotoxic activity against human tumor cell lines LCLC-103H, 5637 and A-427.
引用
收藏
页码:331 / 341
页数:11
相关论文
共 46 条
[1]  
Abdala H, 2000, ARZNEIMITTEL-FORSCH, V50, P479
[2]   DIRECT ACYLAMINATION OF 3-SUBSTITUTED PYRIDINE 1-OXIDES - DIRECTIVE EFFECT OF SUBSTITUENT [J].
ABRAMOVI.RA ;
ROGERS, RB .
JOURNAL OF ORGANIC CHEMISTRY, 1974, 39 (13) :1802-1807
[3]   A DIRECT ALKYL AND ARYL AMINATION OF HETEROAROMATIC NITROGEN COMPOUNDS [J].
ABRAMOVICH, RA ;
SINGER, GM .
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, 1969, 91 (20) :5672-+
[4]   Discovery of GNF-5837, a Selective TRK Inhibitor with Efficacy in Rodent Cancer Tumor Models [J].
Albaugh, Pam ;
Fan, Yi ;
Mi, Yuan ;
Sun, Fangxian ;
Adrian, Francisco ;
Li, Nanxin ;
Jia, Yong ;
Sarkisova, Yelena ;
Kreusch, Andreas ;
Hood, Tami ;
Lu, Min ;
Liu, Guoxun ;
Huang, Shenlin ;
Liu, Zuosheng ;
Loren, Jon ;
Tuntland, Tove ;
Karanewsky, Donald S. ;
Seidel, H. Martin ;
Molteni, Valentina .
ACS MEDICINAL CHEMISTRY LETTERS, 2012, 3 (02) :140-145
[5]   Novel diaryl ureas with efficacy in a mouse model of malaria [J].
Anderson, John W. ;
Sarantakis, Dimitri ;
Terpinski, Jacek ;
Kumar, T. R. Santha ;
Tsai, Han-Chun ;
Kuo, Mack ;
Ager, Arba L. ;
Jacobs, William R., Jr. ;
Schiehser, Guy A. ;
Ekins, Sean ;
Sacchettini, James C. ;
Jacobus, David P. ;
Fidock, David A. ;
Freundlich, Joel S. .
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2013, 23 (04) :1022-1025
[6]  
[Anonymous], 2008, CRYSALIS PRO SOFTW V
[7]   Correlations between the activities of 19 anti-tumor agents and the intracellular glutathione concentrations in a panel of 14 human cancer cell lines:: comparisons with the National Cancer Institute data [J].
Bracht, K ;
Boubakari ;
Grünert, R ;
Bednarski, PJ .
ANTI-CANCER DRUGS, 2006, 17 (01) :41-51
[8]   PREPARATION AND REACTIONS OF 2-NITROPYRIDINE-1-OXIDES [J].
BROWN, EV .
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, 1957, 79 (13) :3565-3566
[9]   A rule of three for fragment-based lead discovery? [J].
Congreve, M ;
Carr, R ;
Murray, C ;
Jhoti, H .
DRUG DISCOVERY TODAY, 2003, 8 (19) :876-877
[10]   Making drugs on proteins: site-directed ligand discovery for fragment-based lead assembly [J].
Erlanson, DA ;
Hansen, SK .
CURRENT OPINION IN CHEMICAL BIOLOGY, 2004, 8 (04) :399-406